Is two serum elevated cortisol levels with Adrenocorticotropic hormone (ACTH) >15 pg/mL and a failed Low-Dose Dexamethasone Suppression Test (LDDST) with a greater than 50% drop sufficient to proceed to Bilateral Inferior Petrosal Sinus Sampling (BIPSS) if Magnetic Resonance Imaging (MRI) is inconclusive?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnostic Criteria for Proceeding to BIPSS in ACTH-Dependent Cushing's Syndrome

Yes, two serum elevated cortisol levels with ACTH >15 pg/mL and a failed Low-Dose Dexamethasone Suppression Test (LDDST) with less than 50% cortisol suppression is sufficient to proceed to Bilateral Inferior Petrosal Sinus Sampling (BIPSS) if MRI is inconclusive. 1, 2

Diagnostic Algorithm for ACTH-Dependent Cushing's Syndrome

  • Confirmation of ACTH-dependent Cushing's syndrome requires:

    • Biochemical evidence of hypercortisolism (elevated serum cortisol) 1, 3
    • ACTH levels >5 ng/L (>1.1 pmol/L), with levels >15 pg/mL clearly indicating ACTH-dependency 3
    • Failed LDDST (cortisol not suppressed by at least 50%) 1
  • After confirming ACTH-dependent Cushing's syndrome, the next step is pituitary MRI 1, 3

  • BIPSS is indicated when:

    • Pituitary MRI is negative or inconclusive (no adenoma identified) 1, 2
    • There is discordance between biochemical testing and imaging findings 1, 2

BIPSS Procedure and Interpretation

  • BIPSS should only be performed:

    • In specialized centers with expertise in the procedure 1
    • By experienced interventional radiologists who regularly perform this procedure 1
    • After confirming hypercortisolemia immediately prior to the procedure to ensure active disease phase (especially important for cyclical Cushing's disease) 1, 2
    • After discontinuing any medical therapy for Cushing's disease 2
  • Diagnostic criteria for confirming pituitary source of ACTH excess:

    • Central-to-peripheral ACTH ratio ≥2:1 before CRH or desmopressin stimulation 1, 2
    • Central-to-peripheral ACTH ratio ≥3:1 after CRH or desmopressin stimulation 1, 2
  • BIPSS may also provide information on tumor lateralization if the inter-petrosal sinus ACTH gradient after stimulation is ≥1.4 between the two sides 1, 2

Important Considerations

  • BIPSS has superior diagnostic accuracy compared to high-dose dexamethasone suppression testing (HDDST), which has limited value in clinical practice with sensitivity of 81% and specificity of only 66.7% for diagnosing pituitary-dependent Cushing's syndrome 4

  • Recent research suggests that urinary free cortisol (UFC) levels can help predict the likelihood of ectopic ACTH syndrome (EAS) vs. Cushing's disease and guide diagnostic approaches:

    • UFC <3× upper limit of normal: very low probability of EAS (0%)
    • UFC 3-10× upper limit of normal: low probability of EAS (6.1%)
    • UFC >10× upper limit of normal: high probability of EAS (66.7%) 5
  • Some centers are exploring non-invasive alternatives combining HDDST with high-resolution contrast-enhanced MRI (hrMRI), which may achieve diagnostic performance comparable to BIPSS with better tumor lateralization accuracy 6

Pitfalls and Caveats

  • Ensure that the patient is not taking exogenous glucocorticoids before testing 1

  • Confirm active hypercortisolism immediately before BIPSS, especially in cases of cyclical Cushing's disease 1, 2

  • Be aware that certain conditions (severe obesity, alcoholism, uncontrolled diabetes) can cause false positive results in screening tests 3

  • BIPSS should not be used as a first-line test but reserved for cases where MRI does not show a clear pituitary adenoma 2

  • False lateralization can occur during BIPSS due to altered pituitary blood flow 2

References

Related Questions

Is it best to collect the dexamethasone suppression test (DST) and adrenocorticotropic hormone (ACTH) level on different days when evaluating for hypercortisolism or Cushing's?
Why does high-dose dexamethasone (a synthetic member of the glucocorticoid class of steroid drugs) suppress pituitary adenoma-induced Cushing's syndrome but not adrenal Cushing's syndrome?
What is the treatment for HDDST?
What is the role of the high dose dexamethasone (DEXA) suppression test in diagnosing Cushing's syndrome?
What is the next step in management for a patient with an elevated dexamethasone suppression test (DST) result?
Is a failed Low-Dose Dexamethasone Suppression Test (LDDST) with two random elevated cortisol levels and normal Adrenocorticotropic Hormone (ACTH) levels sufficient to establish Adrenocorticotropic Hormone (ACTH) dependence?
What is the percentage likelihood of developing a secondary cancer after receiving 3.7 Gigabecquerels (GBq) of radioactive Iodine-131 (I-131)?
Is elevated cortisol with adrenocorticotropic hormone (ACTH) levels greater than 15 and a failed low-dose dexamethasone suppression test (LDDST) with a greater than 50% drop sufficient to diagnose adrenocorticotropic hormone (ACTH)-dependent Cushing's syndrome?
What are the initial ventilator settings for a Chronic Obstructive Pulmonary Disease (COPD) patient in Type 2 respiratory failure?
What's the next step in diagnosis for a patient with Cushing's disease suspected after a Low-Dose Dexamethasone Suppression Test (LDDST) showing more than 50% suppression of cortisol to a level of 6 ug/dL and an inconclusive MRI?
What are the initial invasive ventilator settings for a patient with Chronic Obstructive Pulmonary Disease (COPD) in Type 2 respiratory failure?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.